1. Home
  2. JAGX vs OMH Comparison

JAGX vs OMH Comparison

Compare JAGX & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$2.38

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

SELL

Current Price

$3.28

Market Cap

4.6M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
JAGX
OMH
Founded
2013
2015
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.4M
4.6M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
JAGX
OMH
Price
$2.38
$3.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.0M
75.2K
Earning Date
11-16-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 82.42
N/A
EPS
N/A
★ N/A
Revenue
★ $11,511,000.00
N/A
Revenue This Year
$77.78
$39.14
Revenue Next Year
N/A
$145.74
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.20
$0.06
52 Week High
$41.53
$3.75

Technical Indicators

Market Signals
Indicator
JAGX
OMH
Relative Strength Index (RSI) 45.70 69.23
Support Level $2.12 $2.17
Resistance Level $3.07 $3.75
Average True Range (ATR) 0.52 0.31
MACD -0.40 0.03
Stochastic Oscillator 10.58 75.30

Price Performance

Historical Comparison
JAGX
OMH

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, Digital Marketing Services, and emerging and other services. The firm operates in two segments, which are Brokerage, emerging and another related service; and Estate management services and other related services in Singapore.

Share on Social Networks: